Compare TOVX & TULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOVX | TULP |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 8.5M |
| IPO Year | 2012 | N/A |
| Metric | TOVX | TULP |
|---|---|---|
| Price | $0.17 | $3.96 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.8M | 7.5K |
| Earning Date | 06-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $3.63 |
| 52 Week High | $1.50 | $4.79 |
| Indicator | TOVX | TULP |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 41.52 |
| Support Level | $0.17 | $3.72 |
| Resistance Level | $0.26 | $4.27 |
| Average True Range (ATR) | 0.01 | 0.17 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 3.91 | 42.64 |
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.